Test Overview
Method
High performance liquid chromatography-fluorescence detection (HPLC-FID)
Result Included
Mirtazapine
Aliases/Synonyms
Remeron
Specimen
Specimen Type
Avoid gel separator tubes Serum (Preferred)Plasma (Acceptable)
Containers
Preferred Containers
Red top (no additive)
Acceptable Containers
Green top (Sodium heparin)
Volume
Sample Volume
2 mL
Minimum Volume
0.3 mL
Specimen Comment
Avoid gel separator tubes.
Collection & Handling
Handling Information
Store and send cold or frozen.
Stability
| Ambient | Refrigerated | Frozen |
|---|---|---|
| 72 hours | 14 days | 180 days |
Rejection Criteria
| Criteria | Specification |
|---|---|
| Specimen | Gel-separator tubes |
Performance & Interpretation
Turnaround Time
11 days
Results
Name
Units
Reference Range
Conversion
-
Mirtazapineng/mL4.0 - 40.0
Comment
Expected steady state trough mirtazapine concentrations in patients receiving recommended daily dosages: 4.0-40.0 ng/mL
Toxic range not established
Test performed at: Medtox Laboratories Inc., 402 W. County Road D, St. Paul, MN 55112
Referral Location
Out-of-Country
Interface & Setup
HL7 Interface Codes
| Order Code | Result Name | Result Codes | Units |
|---|---|---|---|
| FMIRT | Mirtazapine | 64814 | ng/mL |
Test Version
Last Updated
2023-03-23